Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Wannabes

Wannabes

Company Mkt cap ($M)
Adv Tissue (ATIS) 131.1
Algos (ALGO) 191.0
AnorMed (TSE:AOM) 184.9
Antisoma (EASD:ASOM) 130.8
Aradigm

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE